T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation.
T cell clonality
T cell clonotyping
T cell receptor sequencing
TCR-β sequencing
Journal
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
21
02
2020
revised:
13
04
2020
accepted:
22
04
2020
pubmed:
18
5
2020
medline:
24
6
2021
entrez:
18
5
2020
Statut:
ppublish
Résumé
Delayed reconstitution of the immune system is a long-recognized complication after allogeneic hematopoietic cell transplantation (HCT). Specifically, loss of T cell diversity has been thought to contribute to infectious complications, graft-versus-host disease (GVHD), and disease relapse. We performed serial high-resolution next-generation sequencing of T cell receptor (TCR)-β in 99 related or unrelated donor (57 unrelated, 42 related) allogeneic HCT recipients (55 with reduced-intensity conditioning, 44 with myeloablative conditioning) during the first 3 months after HCT using the immunoSEQ Assay. We measured T cell fraction, clonality (1- Peilou's evenness) and Daley-Smith richness from recipient samples at multiple time points. In agreement with previous studies, we found that although absolute T cell numbers recover relatively quickly after HCT, T cell repertoire diversity remains diminished. Restricted diversity was associated with conditioning intensity, use of antithymocyte globulin, and donor type. Increased number of expanded clones compared to donor T cell clones at day +30 was associated with the incidence of acute GVHD (hazard ratio [HR], 1.11; P = .00005). Even after exclusion of the 12 patients who developed acute GVHD before day +30, the association between acute GVHD and increased clonal expansion at day +30 remained (HR, 1.098; P = .041), indicating that increased clonal T cell expansion preceded the development of acute GVHD. Our results highlight T cell clonal expansion as a potential novel biomarker for acute GVHD that warrants further study.
Identifiants
pubmed: 32417490
pii: S1083-8791(20)30259-7
doi: 10.1016/j.bbmt.2020.04.026
pmc: PMC8279830
mid: NIHMS1720782
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1567-1574Subventions
Organisme : NCI NIH HHS
ID : T32 CA071345
Pays : United States
Informations de copyright
Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
Références
Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10
pubmed: 26386318
Blood. 2009 Nov 5;114(19):4099-107
pubmed: 19706884
Nat Methods. 2013 Apr;10(4):325-7
pubmed: 23435259
Bone Marrow Transplant. 2015 Sep;50(9):1227-34
pubmed: 26052909
Blood. 2000 Jan 1;95(1):352-9
pubmed: 10607724
Nat Commun. 2013;4:2680
pubmed: 24157944
Leukemia. 2020 May;34(5):1422-1432
pubmed: 31772297
Biol Blood Marrow Transplant. 2006 Mar;12(3):335-45
pubmed: 16503503
JCI Insight. 2016;1(5):
pubmed: 27213183
Chimerism. 2015 Jul 3;6(3):47-9
pubmed: 26745665
Nat Med. 2013 Mar;19(3):372-7
pubmed: 23435170
Biol Blood Marrow Transplant. 2019 May;25(5):868-882
pubmed: 30677510
Haematologica. 2019 Mar;104(3):622-631
pubmed: 30262565
Mol Oncol. 2015 Dec;9(10):2063-70
pubmed: 26404496
J Virol. 2015 Apr;89(8):4517-26
pubmed: 25653453
J Immunol. 2019 Jan 15;202(2):476-483
pubmed: 30541882
Biol Blood Marrow Transplant. 2012 Apr;18(4):565-74
pubmed: 21875503
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1
pubmed: 25529383
Leuk Lymphoma. 2007 Aug;48(8):1618-27
pubmed: 17701594
J Immunol Methods. 2012 Jan 31;375(1-2):14-9
pubmed: 21945395
Blood. 2014 Jun 5;123(23):3664-71
pubmed: 24744269